Eye test may help diagnose ADHD

Article

A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.

Tel Aviv, Israel-A recent study from researchers at Tel Aviv University published in Vision Research found that a test examining involuntary eye movements may help diagnose attention deficit/hyperactive disorder (ADHD) and can predict whether stimulant medication would be an effective treatment for the individual.

Share this pediatric vision checklist with your patients

Currently, doctors diagnose patients with ADHD through medical, behavioral, and social history of both the patient and the family because there are no reliable physiological markers to diagnose the disorder.

But researchers in Tel Aviv saw increased microsaccades and blink rates in adults with ADHD. The study found that there is a direct correlation between ADGD and the inability to suppress eye movement in the anticipation of visual stimuli. The research also found improved performance by the participants after taking methylphenidate, which normalized the suppression of the involuntary eye movements to the average level of the control group.

"We had two objectives going into this research," said Dr. Moshe Fried. "The first was to provide a new diagnostic tool for ADHD, and the second was to test whether ADHD medication really works-and we found that it does. There was a significant difference between the two groups, and between the two sets of tests taken by ADHD participants un-medicated and later medicated."

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Rachelle Lin, OD, MS, FAAO
Paul Karpecki, OD, FAAO
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Rachelle Lin, OD, MS, FAAO, at CRU Eye Symposium 2025
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Rachelle Lin, OD, MS, FAAO, details her presentation on inherited retinal diseases at CRU 2025.
Setting the stage in LA: Neda Shamie, MD, on the 19th annual Controversies in Modern Eye Care meeting
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
© 2025 MJH Life Sciences

All rights reserved.